| Serial Number | 79134609 |
| Word Mark | DIAXONHIT SPECIALTY DIAGNOSTIC SOLUTIONS |
| Filing Date | Friday, March 29, 2013 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, March 29, 2023 |
| Registration Number | 4553916 |
| Registration Date | Tuesday, June 24, 2014 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, April 8, 2014 |
| Description of Mark | The mark consists of the term "DIAXONHIT" with the letters "DIAXON" in gray with a red dot over the letter "i" and the letters "HIT" in red with a gray dot over the letter "i" all positioned above the wording "Specialty Diagnostic Solutions" in gray lettering. |
| Goods and Services | Pharmaceutical products for the treatment of diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical and biological reagents for medical use for diagnostics, namely, chemical and biological reagents for use in tests based on blood or biological biomarkers enabling the identification of patients affected by diseases or being at risk of developing a disease and for enabling the identification of patients responding to specific personalized medical treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; biopharmaceutical products for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular infectious diseases, neurodegenerative diseases and cancers; medical and clinical diagnostic products, namely, beads, microspheres, nucleic acid or antigen banks, nucleic acids, antigens on beads, or on microspheres, on biochips or on other media; DNA libraries, RNA libraries and antigen libraries, namely, biological materials in the nature of tissue and samples of blood for medical diagnosis and companion diagnosis for medical purposes; nucleic acid or antigen sequences, namely, biological materials intended for medical use and medical diagnosis, namely, for decoding the genes and proteins affected by diseases or revealing the transcriptomic signature of patients affected by diseases and for the detection of specific antibodies produced by patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; chemical reagents for medical use contained in diagnostic testing kits for collecting biological samples required for the preservation of the biological material under analysis to carry out the test in appropriate conditions |
| Indication of Colors claimed | The color(s) gray and red is/are claimed as a feature of the mark. |
| Goods and Services | Medical services; veterinary services; medical assistance; consultancy in the field of biotechnology and pharmacy, namely, to assist in the selection of people suffering from diseases for clinical trials and to offer targeted care and personalized medical solutions; hospital services; services for the pharmaceutical industry and pharmacists, those who prepare prescriptions, namely, immunology, infectiology, cancerology, geriatric and neurological services, in order to facilitate diagnoses and undertaking therapy; health care services; telemedicine services |
| Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, especially apparatus and instruments, namely, fluorescent instruments in the nature of fluorescent tracers and fluorescent dye and fluorescence microscope and X-ray fluorescence spectrometer used for identifying diseases, assessing the severity of these diseases, assessing prognoses of these diseases, measuring the progression of a disease; medical devices using beads, microspheres and fluorescent instruments, and biopsies for analyzing blood or other biological materials; apparatus for medical use for analyzing blood or other products of the human body; apparatus for medical diagnosis, namely, kits for taking samples of blood or other products of the human body comprising medical instruments for taking blood, DNA collection for diagnosing diseases, and materials required for the preservation of any product of the human body under analysis to carry out the test under good conditions; spoons for administering medicine; containers specially adapted to the application of medicines, namely, small bags and pouches used for administering medicines; probes for medical use; syringes for medical use; galvanic therapeutic appliances particularly for diagnosing diseases; probes and kits comprised of materials and medical instruments for taking blood samples, for collecting DNA and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers for medical and clinical diagnosis |
| Disclaimer with Predetermined Text | "SPECIALTY DIAGNOSTIC SOLUTIONS" |
| Goods and Services | Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analysis; chemical research; chemistry services, namely, analysis of RNA genes, antigens, tissue and samples of blood or other biological materials; biotechnological project studies for identifying people suffering from diseases and to measure the severity of these diseases, the prognoses, progression and conversion of the disease and to determine the responsiveness of patients to treatments, especially personalized medical treatments; research and development of new products for others;biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis, namely, quantification of nucleic acid content intended for medical and scientific research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DIAXONHIT |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | F-75013 PARIS FR |
| Party Name | DIAXONHIT |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | F-75013 PARIS FR |
| Party Name | DIAXONHIT |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | F-75013 PARIS FR |
| Event Date | Event Description |
| Sunday, October 22, 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Sunday, October 22, 2023 | DEATH OF INTERNATIONAL REGISTRATION |
| Sunday, April 3, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Sunday, February 27, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Saturday, February 26, 2022 | INVALIDATION PROCESSED |
| Tuesday, October 26, 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, February 26, 2021 | CANCELLED SECTION 71 |
| Friday, January 23, 2015 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, December 9, 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, December 9, 2014 | FINAL DISPOSITION PROCESSED |
| Wednesday, September 24, 2014 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, June 24, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 8, 2014 | PUBLISHED FOR OPPOSITION |
| Friday, April 4, 2014 | NOTIFICATION PROCESSED BY IB |
| Wednesday, March 19, 2014 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, March 19, 2014 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, March 19, 2014 | NOTICE OF PUBLICATION |
| Sunday, March 2, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 24, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 6, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 6, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 3, 2014 | ASSIGNED TO LIE |
| Friday, January 24, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 23, 2013 | REFUSAL PROCESSED BY IB |
| Wednesday, September 4, 2013 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, September 4, 2013 | REFUSAL PROCESSED BY MPU |
| Sunday, September 1, 2013 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, August 31, 2013 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 27, 2013 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 23, 2013 | ASSIGNED TO EXAMINER |
| Friday, August 23, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 22, 2013 | SN ASSIGNED FOR SECT 66A APPL FROM IB |